SomnoMed Limited
SomnoMed Limited, headquartered in Australia, is a leading innovator in the field of sleep medicine, specialising in the development of oral appliances for the treatment of obstructive sleep apnoea (OSA). Founded in 2004, the company has established a strong presence in key markets across North America, Europe, and Asia-Pacific, positioning itself as a trusted name in sleep therapy solutions. SomnoMed's flagship products, including the SomnoDent range, are distinguished by their patient-centric design and customisation options, ensuring comfort and efficacy. The company has achieved significant milestones, including regulatory approvals and partnerships with dental professionals, solidifying its market position as a pioneer in non-invasive sleep treatment. With a commitment to improving patient outcomes, SomnoMed continues to lead the way in advancing sleep health solutions globally.
DitchCarbon Score
How does SomnoMed Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SomnoMed Limited's score of 11 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
SomnoMed Limited's reported carbon emissions
SomnoMed Limited, headquartered in Australia, currently does not have any available carbon emissions data for the most recent year, as indicated by the absence of specific figures. Consequently, there are no reported emissions in kg CO2e, nor are there any documented reduction targets or climate pledges. The company has not established any Science-Based Targets Initiative (SBTi) reduction targets or other significant climate commitments at this time. As such, SomnoMed Limited's approach to carbon emissions and climate action remains unclear, with no inherited data from a parent organization or corporate family to provide further context. In summary, SomnoMed Limited has yet to disclose its carbon emissions or set formal reduction initiatives, highlighting a potential area for future development in their sustainability strategy.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
SomnoMed Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
